UBE2C and brain neoplasm: The overexpression of UBE2C has been described in many human cancers, namely breast, lung, thyroid, endometrial, renal, prostate, pancreatic, esophageal, hepatocellular, gastrointestinal, and brain tumors [47,52,53,54].